About BiomeSense
BiomeSense is a company based in Chicago (United States) founded in 2018 by Jack Gilbert, Savas Tay, and Kevin Honaker.. BiomeSense has raised $8.43 million across 5 funding rounds from investors including HHS, Bluestein Ventures and Harvest Ridge Capital. The company has 9 employees as of December 31, 2024. BiomeSense offers products and services including GutLab Technology, MetaBiome AI Platform, and Full Laboratory Services. BiomeSense operates in a competitive market with competitors including Seed, Omega Therapeutics, Azitra, OptiBiotix Health and OGI Bio, among others.
- Headquarter Chicago, United States
- Employees 9 as on 31 Dec, 2024
- Founders Jack Gilbert, Savas Tay, Kevin Honaker
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.43 M (USD)
in 5 rounds
-
Latest Funding Round
$6.18 M (USD), Seed
Feb 14, 2023
-
Investors
HHS
& 6 more
-
Employee Count
9
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BiomeSense
BiomeSense offers a comprehensive portfolio of products and services, including GutLab Technology, MetaBiome AI Platform, and Full Laboratory Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables continuous at-home gut microbiome monitoring for research.
Analyzes microbiome data to identify patterns and clinical insights.
Offers sequencing and support for microbiome data generation.
Funding Insights of BiomeSense
BiomeSense has successfully raised a total of $8.43M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $6.18 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $6.2M
-
First Round
First Round
(25 Jun 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Seed - BiomeSense | Valuation | Bluestein Ventures | |
| Jun, 2021 | Amount | Grant - BiomeSense | Valuation |
investors |
|
| Jan, 2021 | Amount | Grant - BiomeSense | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BiomeSense
BiomeSense has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Bluestein Ventures and Harvest Ridge Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are provided in the food industry.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BiomeSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BiomeSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomesense Comparisons
Competitors of BiomeSense
BiomeSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Seed, Omega Therapeutics, Azitra, OptiBiotix Health and OGI Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Platform for human genome study is provided for precision medicine.
|
|
| domain | founded_year | HQ Location |
Microbiome-based therapeutics for skin conditions like eczema are developed.
|
|
| domain | founded_year | HQ Location |
Microbial strains are developed for treating human metabolic diseases.
|
|
| domain | founded_year | HQ Location |
Modular automation system for routine microbial culturing is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomesense
Frequently Asked Questions about BiomeSense
When was BiomeSense founded?
BiomeSense was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is BiomeSense located?
BiomeSense is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of BiomeSense?
Kevin Honaker is the current CEO of BiomeSense. They have also founded this company.
Is BiomeSense a funded company?
BiomeSense is a funded company, having raised a total of $8.43M across 5 funding rounds to date. The company's 1st funding round was a Grant of $255.66K, raised on Jun 25, 2019.
How many employees does BiomeSense have?
As of Dec 31, 2024, the latest employee count at BiomeSense is 9.
What does BiomeSense do?
Developer of AI-enabled technology platform for microbiome data generation and analysis. The company provides continuous, comprehensive microbiome data and AI-enabled bioinformatics. It offers GutLab technology for continuous tracking of the patients gut microbiome throughout the treatment journey. The companys MetaBiome AI Platform transforms and analyzes the data using time-series analyses, enabling identification of clinically-relevant shifts and patterns. The platform unlocks host-microbiome interactions, such as a signature suggesting the gut microbiome may be a biomarker for active tumor burden. The company partners with scientists, institutions, and companies conducting clinical research into the gut microbiome, with a focus on personalized biomarker discovery and product development.
Who are the top competitors of BiomeSense?
BiomeSense's top competitors include Omega Therapeutics, Azitra and Seed.
What products or services does BiomeSense offer?
BiomeSense offers GutLab Technology, MetaBiome AI Platform, and Full Laboratory Services.
Who are BiomeSense's investors?
BiomeSense has 7 investors. Key investors include HHS, Bluestein Ventures, Harvest Ridge Capital, Seerave Foundation, and SOSV.